Stock Screener ETF Screener

Penny Stock Screener Technical Analysis Screener

Dividend Center Best Dividend Stocks

Best High Yield Dividend Stocks Dividend Aristocrats Dividend Stock Comparison

Dividend Calculator Dividend Returns Comparison Dividend Calendar

My Experts Top Analysts Top Financial Bloggers Top-Performing Corporate Insiders Top Hedge Fund Managers Top Research Firms Top Individual Investors

Education

Personal Finance How To Use TipRanks TipRanks Labs Webinar Center Glossary FAQs

About Us

About TipRanks Contact Us Careers Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Advertise with Us Top Online Brokers Become an Affiliate TipRanks News Wire Arrived EquityMultiple

Follow Us

TOOLS

Top Insiders Stocks

Notification Center

Top Smart Score Stocks

Plans & Pricing

Research Tools

Trending Stocks

Most Visited Websites

Daily Feeds

Daily Analyst Ratings

Daily Insider Trading Tracker

Calendars

Earnings Calendar

Dividend Calendar

Economic Calendar

Market Holidays

Economic Indicators

Economic Indicators Center

Unemployment Rate

Federal Funds Rate

Class Actions

Calculators

Dividend Calculator

Dividend Yield Calculator

Options Profit Calculator

Dollar Cost Averaging

Penny Stock Screener

Technical Analysis Screener

Dividend Center

Best Dividend Stocks

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

Personal Finance Center

Investing & Retirement

Spending & Savings

Calculators

Compound Interest Calculator

Mortgage Calculator

Auto Loan Calculator

Student Loan Calculator

401k Retirement Calculator

Enterprise Solutions

Education

How To Use TipRanks

About Us

Working with TipRanks

Enterprise Solutions

Top Online Brokers

Become an Affiliate

TipRanks News Wire

Follow Us

Io Biotech, Inc. (IOBT)

:IOBT

US Market

IOBT

IO Biotech

Analyst Forecasts

Technical Analysis

RESEARCH TOOLS

Top Analyst Stocks

Top Smart Score Stocks

reports

Holding IOBT?

Track your performance easily

IO Biotech (IOBT) Stock News & Sentiment

317 Followers

IO Biotech Secures €57.5 Million EIB Loan Facility

Company Announcements

IO Biotech Secures €57.5 Million EIB Loan Facility

1M ago

IO Biotech’s Promising Phase 3 Cancer Vaccine Trial Advances

Company Announcements

IO Biotech’s Promising Phase 3 Cancer Vaccine Trial Advances

5M ago

IOBT Upcoming Earnings Report: What to Expect?

Pre-Earnings

IOBT Upcoming Earnings Report: What to Expect?

6M ago

IOBT Upcoming Earnings Report: What to Expect?

Pre-Earnings

IOBT Upcoming Earnings Report: What to Expect?

9M ago

IO Biotech Board Member Jack Nielsen Resigns Due to Health

Company Announcements

IO Biotech Board Member Jack Nielsen Resigns Due to Health

9M ago

2 “Strong Buy” Penny Stocks That Could Rally Over 300%

Stock Analysis & Ideas

2 “Strong Buy” Penny Stocks That Could Rally Over 300%

2y ago

Morgan Stanley Predicts Over 100% Rally for These New “Strong Buy” Stocks

Stock Analysis & Ideas

Morgan Stanley Predicts Over 100% Rally for These New “Strong Buy” Stocks

3y ago

More IOBT News >

IOBT News on the Web

2025-01-10

IO Biotech enrols all subjects in Phase II trial of cancer combination therapy

Clinical Trials Arena

Neutral

2024-11-12

Positive Outlook for IO Biotech Amid Promising Clinical Developments in Melanoma and Head & Neck Cancer Trials

TipRanks News

Bullish

2024-10-04

IO Biotech Announces Two Poster Presentations at the Society for Immunotherapy of Cancer’s 39th Annual Meeting

Yahoo Finance

Neutral

2024-09-16

Piper Sandler Sticks to Its Buy Rating for IO Biotech (IOBT)

TipRanks News

Bullish

2024-09-14

IO Biotech Announces Positive Results from Phase 2 Trial of IO102-IO103 in the First-line Treatment of Advanced Head and Neck Cancer

Yahoo Finance

Neutral

2024-09-02

IO Biotech’s melanoma treatment trial to continue after IDMC review

Clinical Trials Arena

Neutral

2024-08-31

IO Biotech's Phase 3 Trial Data Fails To Show Superiority In ORR For IO102-IO103 With KEYTRUDA

rttnews

Neutral

2024-08-30

IO Biotech Updates on Pivotal Phase 3 Trial of IO102-IO103 in Combination with KEYTRUDA® as a First-Line Treatment for Patients with Advanced Melanoma

Yahoo Finance

Neutral

News Score - Last 7 Days

Neutral

IOBT

Sector Average

Media Buzz

This Week0 articles

Weekly Average0 articles

News Sentiment

This Week59%

Sector Average63%

See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is IOBT’s Media Buzz Sentiment?

Currently, no data Available

What is IOBT’s weekly average amount of articles?

Currently, no data Available

What is IOBT’s News Sentiment?

59% of articles about IOBT were positive this week, compared to its sector average of 63%.

Healthcare Stocks that are Trending in the News

IRONDisc Medicine

RIGLRigel

JNJJohnson & Johnson

BAXBaxter International

EOLSEvolus

Showing the stocks with the most bullish news sentiment over the past week

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing